In addition studies in IL-5 deficient mice [7] as well as in human subjects with asthma treated with anti-IL-5 [17] demonstrate reduced numbers of eosinophils, reduced TGF-β1+ eosinophils, and reduced airway remodeling. Here, TGFB1 is linked to asthma.